4//SEC Filing
Kirson Eilon D. 4
Accession 0001209191-18-038050
CIK 0001645113other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:24 PM ET
Size
10.6 KB
Accession
0001209191-18-038050
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Kirson Eilon D.
Chief Science Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2018-06-13$14.37/sh+30,750$441,878→ 70,332 total - Exercise/Conversion
Options to Buy Ordinary Shares
2018-06-13+30,750→ 235,335 totalExercise: $14.37Exp: 2025-02-23→ Ordinary Shares (30,750 underlying) - Exercise/Conversion
Ordinary Shares
2018-06-13$11.46/sh+37,500$429,750→ 107,832 total - Exercise/Conversion
Options to Buy Ordinary Shares
2018-06-13+37,500→ 37,500 totalExercise: $11.46Exp: 2026-02-24→ Ordinary Shares (37,500 underlying)
Footnotes (1)
- [F1]Options exercised were fully vested as of the date hereof.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001654356
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:24 PM ET
- Size
- 10.6 KB